A failed transfer of a good-quality embryo is one of the hardest things to make sense of. The clinical numbers said the embryo was strong. The lining looked right on the scan. The protocol was followed. And still, no pregnancy.
When that happens, the conversation often turns to whether the timing of transfer was actually correct for your body. Whether your personal window of receptivity is shifted from the standard. Whether a more bespoke approach to progesterone timing would change the next outcome.
That is the question the ERA test was designed to answer.
The ERA test — endometrial receptivity analysis — examines the genetic activity of the uterine lining at the moment of biopsy, with the aim of identifying a personal window of implantation that may differ from the standard.
It is also one of the add-ons formally reviewed by the Human Fertilisation and Embryology Authority, the UK’s independent fertility regulator. The HFEA publishes evidence reviews on the optional tests and procedures offered alongside standard IVF, and their assessments are widely used internationally by clinicians and patients trying to decide what is worth doing next.
What the ERA test is
The ERA test is a biopsy of the uterine lining, taken during a mock cycle that mimics the timing of a frozen embryo transfer. Around 200 genes associated with endometrial receptivity are analysed, and the lining is classified as receptive, pre-receptive or post-receptive at the moment of biopsy.
If the result is pre-receptive, the next transfer may be done with more hours of progesterone before transfer. If post-receptive, fewer. If receptive, standard timing is confirmed.
The aim is to personalise the implantation window for women whose cycles have not produced a pregnancy on standard timing.
Where the ERA test has a clearer clinical role
The strongest case for the ERA test sits in a narrow group.
Women who have had multiple failed transfers of chromosomally tested or otherwise high-quality embryos, where standard endometrial preparation has not resulted in implantation, and where a shifted window of receptivity is being investigated as a possible explanation.
In a small subset of these patients, the ERA test does identify a receptivity window outside the standard timing. For those women, adjusting the hours of progesterone before transfer is a logical clinical response.
That is the corridor where the test was originally designed to be useful.
What the regulator assessment shows
The HFEA reviews each add-on against the evidence for whether it improves the chance of a live birth.
On the ERA test, the published assessment reports that high-quality randomised trials have not shown that ERA-guided timing improves live birth rates for most patients — including, in the largest study available, women with recurrent implantation failure, the group the test was originally designed for.
This is not a finding that timing does not matter. It is a finding that the test, as currently performed, has not yet been shown to identify the timing change that leads to more live births in the patients it is most often offered to.
If your situation matches the narrow corridor above, the ERA test may still be worth discussing with your clinic. If it does not, the assessment is useful information to bring into that conversation about whether testing or a different approach makes more sense as your next step.
The point of the regulator’s work is not to override clinical judgment. It is to give patients and clinicians a shared evidence base to discuss.
What no add-on can change
The ERA test identifies a window. It does not prepare the lining that is offered up at that window.
By the time the test or transfer takes place, the receptivity of the endometrium has already been shaped — by lining thickness, blood flow to the uterus, hormonal steadiness, glucose regulation, inflammatory load, thyroid function, micronutrient status, and the broader gut and vaginal microbiome.
These are the variables that determine whether a transferred embryo, at any timing, has a body that is genuinely ready to receive it.
A receptive result on a mock cycle does not guarantee the same receptivity months later in the actual transfer cycle. A non-receptive result guides timing but does not address the underlying physiology that produced the result in the first place.
Even with personalised timing and a good-quality embryo, more than 1 in 3 frozen transfers do not result in a live birth. The endometrial environment during the two-week wait is the variable that remains within your influence.
The Now Baby FET Implantation Meal Plan is a fourteen-day, practitioner-designed nutritional protocol to follow from the day after transfer.
Evidence-based peace of mind for the two-week wait
The FET Implantation Meal Plan is structured to support each stage of implantation — secure embedding, early circulatory development, balanced immune signalling, and the early hormonal and metabolic conditions that pregnancy depends on. Every meal has been professionally analysed using clinical nutrition software so the macronutrient and micronutrient profile is balanced and consistent.
What it gives you is a decision already made. You are not standing in the kitchen during the most important fortnight of your cycle wondering whether what you are eating is helping. The plan has been designed for these specific days, by a fertility nutritionist, against the physiology of implantation. Your job is to follow it.
That is what evidence-based peace of mind looks like during the two-week wait. Not a promise about outcome. A clear nutritional structure to follow, designed for the biology you are in.
You didn’t come this far to wing it.
